Skip to main content
OpenTrials
Completed

NCT Number: NCT00136799

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mixed Dyslipidemia Dyslipidemias Hypercholesterolemia Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Novartis

Shanghai, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mixed dyslipidemia
  • Primary hypercholesterolemia

Exclusion criteria

  • Pregnant or lactating women
  • Age > 18 years

Other protocol-defined inclusion and exclusion criteria may apply.

Treatment and study plan

Fluvastatin

Drug

Primary outcomes

  1. Percent change from baseline in low density lipoprotein cholesterol after 12 weeks

Secondary outcomes

  1. Percent change from baseline in total cholesterol after 12 weeks

  2. Percent change from baseline in high density lipoprotein cholesterol after 12 weeks

  3. Percent change from baseline in total triglycerides after 12 weeks

Sponsors and collaborators

Lead sponsor

Novartis

Industry

Registry information

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Aug 29, 2005
Registry last updated
Feb 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.